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An 85-year-old man, formerly heavy smoker, was referred after a 6-month history of weight loss and increasing 
weakness. The patient reported an occupational exposure to 
asbestos due to working over 30 years in a shipyard. The chest 
radiograph showed bilateral pleural calcifications distributed 
unevenly from the lung base to the apex (Fig.1). Chest com-
puted tomography demonstrated a left lower lobe mass sus-
picious for lung cancer (Fig.2). After detailed discussion of 
possible therapeutic options, the patient refused further diag-
nostic work-up and treatment.
Lung cancer can be caused by asbestos exposure.1 The 
association between lung cancer and asbestos plaques has 
been considered at best controversial.2 However, recent evi-
dence obtained from a study on more than 5400 male individ-
uals enrolled in an asbestos-related disease screening program 
confirmed that, after adjustment for smoking, lung cancer 
mortality was associated with the detection of pleural plaques 
(hazard ratio = 2.41; 95% confidence interval = 1.21–4.85).2 
Contrary to self-reported asbestos exposure, objective estima-
tion of asbestos exposure may also reliably serve as predic-
tor of lung cancer development.3,4 However, the latter entails 
significant allocation of resources and expertise and may be 
difficult to incorporate in a public health screening program.5,6 
In conclusion, although the presence of pleural plaques could 
be an independent risk factor for lung cancer,2 whether the 
concomitant detection of pleural plaques in asymptomatic 
patients with history of asbestos exposure may justify screen-
ing remains to be seen.
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FIGURE 1.  Chest radiograph demonstrating diffuse pleural 
plaques like tongues of flames arising from the diaphragm.
FIGURE 2.  Chest computed tomography showing a left 
lower lobe mass suspicious for lung cancer surrounded by 
pleural plaques.
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